Managing medical complications and recurrence after surgery for Crohn's disease

Current Gastroenterology Reports

Volumn 10, Issue 6, 2008, Pages 606-611

  Shen, Bo ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BUDESONIDE; CASPASE RECRUITMENT DOMAIN PROTEIN 15; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METRONIDAZOLE; ORNIDAZOLE; PLACEBO; PREBIOTIC AGENT; PROBIOTIC AGENT; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ABDOMINAL RADIOGRAPHY; ABSENCE OF SIDE EFFECTS; BACTERIAL COLONIZATION; BACTEROIDES; BALLOON DILATATION; BIFIDOBACTERIUM; CAPSULE ENDOSCOPY; CIGARETTE SMOKING; CLINICAL TRIAL; COLON RESECTION; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE DURATION; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG WITHDRAWAL; END TO END ANASTOMOSIS; ENDOSCOPIC SURGERY; ENTERIC FEEDING; ENTEROCOCCUS; ESCHERICHIA COLI; FUSOBACTERIUM; GENETIC VARIABILITY; HIGH RISK PATIENT; HUMAN; LACTOBACILLUS JOHNSONII; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; POSTOPERATIVE INFECTION; PROCTOCOLECTOMY; RECURRENCE RISK; RECURRENT DISEASE; REVIEW; RISK FACTOR; SMALL INTESTINE RESECTION; SURGICAL TECHNIQUE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

CROHN DISEASE; HUMANS; INCIDENCE; POSTOPERATIVE COMPLICATIONS; PREVALENCE; RECURRENCE; RISK FACTORS;

EID: 60749095041     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-008-0109-5     Document Type: Review

References (64)

1. Sachar DB: Indications for surgery in inflammatorA bowel disease: a gastroenterologist's opinion. In Inflammatory Bowel Disease. Edited by Kirsner JB. Philadelphia: WB Saunders; 2000:611-615.
2. Dhillon S, Loftus EV Jr, Tremaine WJ, et al.: The natural history of surgery for ulcerative colitis in a population-based cohort from Olmsted County, Minnesota [abstract]. Am J Gastroenterol 2005, 100(Suppl):S303.
3. Rutgeerts P, Geboes K, Vantrappen G, et al.: Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990, 99:956-963.
4. McLeod RS, Wolff BG, Steinhart H, et al.: Risk and significance of endoscopic/radiologic evidence of recurrent Crohn's disease. Gastroenterology 1997, 113:1823-1827.
5. Borley NR, Mortensen NJ, Jewell DP: Preventing postoperative recurrence of Crohn's disease. Br J Surg 1997, 84:1493-1502.
6. Sachar DB: The problem of postoperative recurrence of Crohn's disease. Med Clin North Am 1990, 74:183-188.
7. Baldassano RN, Han PD, Jeshion WC, et al.: Pediatric Crohn's disease: risk factors for postoperative recurrence. Am J Gastroenterol 2001, 96:2169-2176.
8. Janowitz HD, Croen EC, Sachar DB: The role of the fecal stream in Crohn's disease: An historical and analytic review. Inflamm Bowel Dis 1998, 4:29-39.
9. Zelas P, Jagelman DG: Loop illeostomy in the management of Crohn's colitis in the debilitated patient. Ann Surg 1980, 191:164-168.
10. Rutgeerts P, Goboes K, Peeters M, et al.: Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 1991, 338:771-774.
11. Neut C, Bulois P, Desreumaux P, et al.: Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease. Am J Gastroenterol 2002, 97:939-946.
12. Greenstein AI, Lachman P, Sachar DB, et al.: Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut 1988, 29:588-592.
13. Scarpa M, Angriman I, Barollo M, et al.: Risk factors for recurrence of stenosis in Crohn's disease. Acta Biomed 2003, 74(Suppl 2):80-83.
14. Sutherland LR, Ramcharan S, Bryant H, et al.: Effect of cigarette smoking on recurrence of Crohn's disease. Gastroenterology 1990, 98(5 Pt 1):1123-1128.
15. Cottone M, Rosselli M, Orlando A, et al.: Smoking habits and recurrence in Crohn's disease. Gastroenterology 1994, 106:643-648.
16. Avidan B, Sakhnini E, Lahat A, et al.: Risk factors regarding the need for a second operation in patients with Crohn's disease. Digestion 2005, 72:248-253.
17. Kane SV, Flicker M, Katz-Nelson F: Tobacco use is associated with accelerated clinical recurrence of Crohn's disease after surgically induced remission. J Clin Gastroenterol 2005, 39:32-35.
18. Michelassi F, Balestracci T, Chappell R, Block GE: Primary and recurrent Crohn's. Experience with 1379 patients. Ann Surg 1991, 214:230-240.
19. Heimann TM, Greenstein AJ, Lewis B, et al.: Prediction of early symptomatic recurrence after intestinal resection in Crohn's disease. Ann Surg 1993, 218:294-298.
20. Lautenbach E, Berlin JA, Lichtenstein GR: Risk factors for early postoperative recurrence of Crohn's disease. Gastroenterology 1998, 115:259-267.
21. Simillis C, Purkayastha S, Yamamoto T, et al.: A meta-analysis comparing conventional end-to-end anastomosis vs. other anastomotic configurations after resection in Crohn's disease. Dis Colon Rectum 2007, 50:1674-1687.
22. Fichera A, Lovadina S, Rubin M, et al.: Patterns and operative treatment of recurrent Crohn's disease: A prospective longitudinal study. Surgery 2006, 140:649-654.
23. Yamamoto T, Umegae S, Kitagawa T, Matsumoto K: Postoperative change of mucosal inflammation at strictureplasty segment in Crohn's disease: cytokine production and endoscopic and histologic findings. Dis Colon Rectum 2005, 48:749-757.
24. Ferrante M, de Hertogh G, Hlavaty T, et al.: The value of myenteric plexitis to predict early postoperative Crohn's disease recurrence. Gastroenterology 2006, 130:1595-1606.
25. Alvarez-Lobos M, Arostegui JI, Sans M, et al.: Crohn's disease patients carrying Nod2/CARD15 gene variants have an increased and early need for first surgery due to stricturing disease and higher rate of surgical recurrence. Ann Surg 2005, 242:693-700.
26. Keh C, Shatari T, Yamamoto T, et al.: Jejunal Crohn's disease is associated with a higher postoperative recurrence rate than ileocaecal Crohn's disease. Colorectal Dis 2005, 7:366-368.
27. D'Haens GR, Gasparaitis AE, Hanauer SB: Duration of recurrent ileitis after ileocolonic resection correlates with presurgical extent of Crohn's disease. Gut 1995, 36:715-717.
28. Zalev AH, Deitel W, Kundu S, Tomlinson G: Radiologic appearance of recurrent ileal Crohn disease. Abdom Imaging 2005, 30:665-670.
29. Yamamoto T, Fazio VW, Tekkis PP: Safety and efficacy of strictureplasty for Crohn's disease: A systematic review and meta-analysis. Dis Colon Rectum 2007, 50:1968-1986.
30. Caprilli R, Gassull MA, Escher JC, et al.: European evidence based consensus on the diagnosis and management of Crohn's disease: Special situations. Gut 2006, 55(Suppl 1):136-158.
31. Kurer MA, Stamou KM, Wilson TR, et al.: Early symptomatic recurrence after intestinal resection in Crohn's disease is unpredictable. Colorectal Dis 2007, 9:567-571.
32. Carter MJ, Lobo AJ, Travis SP: Guidelines for the management of inflammatory bowel disease in adults. Gut 2004, 53(Suppl 5):V1-V16.
33. Strong SA, Koltun WA, Hyman NH, Buie WD: Practice parameters for the surgical management of Crohn's disease. Dis Colon Rectum 2007, 50:1735-1746.
34. Viscido A, Corrao G, Taddei G, Caprilli R: "Crohn's disease activity index" is inaccurate to detect the post-operative recurrence in Crohn's disease. A GISC study. Ital J Gastroenterol Hepatol 1999, 31:274-279.
35. Olaison G, Smedh K, Sjodahl R: Natural course of Crohn's disease after ileocolic resection: Endoscopically visualized ileal ulcers preceding the symptoms. Gut 1992, 33:331-335.
36. Biancone L, Calabrese E, Petruzziello C, et al.: Wireless capsule endoscopy and small intestine contrast ultrasonography in recurrence of Crohn's disease. Inflamm Bowel Dis 2007, 13:1256-1265.
37. Parente F, Sampietro GM, Molteni M, et al.: Behaviour of the bowel wall during the first year after surgery is a strong predictor of symptomatic recurrence of Crohn's disease: A prospective study. Aliment Pharmacol Ther 2004, 20:959-968.
38. Maccioni F, Viscido A, Marini M, et al.: MRI evaluation of Crohn's disease of the small and large bowel with the use of negative superparamagnetic oral contrast agents. Abdom Imaging 2002, 27:384-393.
39. Bourreille A, Jarry M, D'Halluin PN, et al.: Wireless capsule endoscopy versus ileocolonoscopy for the diagnosis of postoperative recurrence of Crohn's disease: A prospective study. Gut 2006, 55:978-983.
40. Pons Beltran V, Nos P, Bastida G, et al.: Evaluation of postsurgical recurrence in Crohn's disease: A new indication for capsule endoscopy? Gastrointest Endosc 2007, 66:533-540.
41. Kennedy ED, To T, Steinhart AH, et al.: Do patients consider postoperative maintenance therapy for Crohn's disease worthwhile? Inflamm Bowel Dis 2008, 14:224-235.
42. Achkar JP, Hanauer SB: Medical therapy to reduce postoperative Crohn's disease recurrence. Am J Gastroenterol 2000, 95:1139-1146.
43. Lochs H, Mayer M, Fleig WE, et al.: Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's disease study VI. Gastroenterology 2000, 118:264-273. [Published erratum appears in Gastroenterology 2000, 119: 280.]
44. Gamma C, Giunta M, Rosselli M, Cottone M: Mesalamine in the maintenance of Crohn's disease: A meta-analysis adjusted for confounding variables. Gastroenterology 1997, 113:1465-1473.
45. Caprilli R, Cottone M, Tonelli F, et al.: Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease: A pragmatic, double-blind, randomized controlled trial. Aliment Pharmacol Ther 2003, 17:517-523.
46. Rutgeerts P, Hiele M, Geboes K, et al.: Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 1995, 108:1617-1621.
47. Rutgeerts P, Van Assche G, Vermeire S, et al.: Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: A randomized, double-blind, placebo-controlled trial. Gastroenterology 2005, 128:856-861.
48. Ewe K, Bottger T, Buhr HJ, et al.: Low-dose budesonide treatment for prevention of postoperative recurrence of Crohn's disease: A multicentre randomized placebo-controlled trial. German Budesonide Study Group. Eur J Gastroenterol Hepatol 1999, 11:277-282.
49. Hellers G, Cortot A, Jewell D, et al.: Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group. Gastroenterology 1999, 116:294-300.
50. Domènech E, Mañosa M, Bernal I, et al.: Impact of azathioprine on the prevention of postoperative Crohn's disease recurrence: Results of a prospective, observational, long-term follow-up study. Inflamm Bowel Dis 2008, 14:508-513.
51. Alves A, Panis Y, Joly F, et al.: Could immunosuppressive drugs reduce recurrence rate after second resection for Crohn disease? Inflamm Bowel Dis 2004, 10:491-495.
52. Hanauer SB, Korelitz BI, Rutgeerts P, et al.: Postoperative maintenance of Crohn's disease remission with 6-mercapto purine, mesalamine, or placebo: A 2-year trial. Gastroenterology 2004, 127:723-729.
53. Herfarth H, Tjaden C, Lukas M, et al.: Adverse events in clinical trials with azathioprine and mesalamine for prevention of postoperative recurrence of Crohn's disease. Gut 2006, 55:1525-1526.
54. Ardizzone S, Maconi G, Sampietro GM, et al.: Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease. Gastroenterology 2004, 127:730-740.
55. Sorrentino D, Terrosu G, Avellini C, et al.: Prevention of postoperative recurrence of Crohn's disease by infliximab. Eur J Gastroenterol Hepatol 2006, 18:457-459.
56. Sorrentino D, Terrosu G, Avellini C, Maiero S: Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn disease [letter]. Arch Intern Med 2007, 167:1804-1807.
57. Chermesh I, Tamir A, Reshef R, et al.: Failure of Synbiotic 2000 to prevent postoperative recurrence of Crohn's disease. Dig Dis Sci 2007, 52:385-389.
58. Marteau P, Lémann M, Seksik P, et al.: Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: A randomised, double blind, placebo controlled GETAID trial. Gut 2006, 55:842-847.
59. Prantera C, Scribano ML, Falasco G, et al.: Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: A randomised controlled trial with Lactobacillus GG. Gut 2002, 51:405-409.
60. Esaki M, Matsumoto T, Hizawa K, et al.: Preventive effect of nutritional therapy against postoperative recurrence of Crohn disease, with reference to findings determined by intra-operative enteroscopy. Scand J Gastroenterol 2005, 40:1431-1437.
61. Yamamoto T, Nakahigashi M, Umegae S, et al.: Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohn's disease: A prospective, non-randomized, parallel, controlled study. Aliment Pharmacol Ther 2007, 25:67-72.
62. Hoffmann JC, Heller F, Faiss S, et al.: Through the endoscope balloon dilation of ileocolonic strictures: Prognostic factors, complications, and effectiveness. Int J Colorectal Dis 2008, 23:689-696.
63. Biancone L, Cretella M, Tosti C, et al.: Local injection of infliximab in the postoperative recurrence of Crohn's disease. Gastrointest Endosc 2006, 63:486-492.
64. Dejaco C, Lichtenberger C, Miehsler W, et al.: An open-label pilot study of granulocyte colony-stimulating factor for the treatment of severe endoscopic postoperative recurrence in Crohn's disease. Digestion 2003, 68:63-70.